Management Options for Primary Hepatocellular Carcinoma: An overview

References

• Nubia M, Bosch X. Epidemiology of hepatocellular carcinoma. Neoplasms of the liver, K Okuda, K G Ishak. Springer-Verlag, Tokyo 1987; 3–19
   Google Scholar
• Bruix J, Calvet X, Bru C, Rodes J. Clinical pattern and natural history of hepatocellular carcinoma. Eur Clin Digest Dis 1992; 1: 97–102
   Google Scholar
• Beasley R P, Hwang L Y. Hepatocellular carcinoma and hepatitis B virus. Semin Liver Dis 1984; 4: 113–21
   PubMed Web of Science ®Google Scholar
• Tsukuma H, Hiyama T, Tanaka S. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993; 328: 1797–801
   PubMed Web of Science ®Google Scholar
• Brechot C. Hepatitis B virus and primary liver cancer: a molecular approach. Eur Clin Digest Dis 1992; 1: 86–96
   Google Scholar
• Okuda K, Ohtsuki T, Obata H. National history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 1985; 56: 918–28
   PubMed Web of Science ®Google Scholar
• Sheu J C, Sung J L, Huang E. Intratumour injection of absolute ethanol under ultrasound guidance for the treatment of small hepatocellular carcinoma. Hepatogastroenterol 1987; 34: 255–61
   PubMedGoogle Scholar
• Livraghi T, Salmi A, Bolondi L. Three-year survival rate of small HCC treated by percutaneous ethanol injection: a study of 86 patients. Eur Clin Digest Dis 1992; 1: 121–7
   Google Scholar
• Zhou X D, Tang Z Y, Yu Y Q. A seventeen-year experience of cryosurgery for primary liver cancer. Eur Clin Digest Dis 1992; 1: 157–62
   Google Scholar
• Zhou X D, Zhou T, Yu Y, Ma A. Clinical evaluation of cryosurgery in the treatment of primary liver cancer. Report of 60 cases. Cancer 1988; 61: 1889–92
   PubMed Web of Science ®Google Scholar
• Gage A A, Fazekas G, Riley E E, Jr. Freezing injury to large blood vessels in dogs with comments on the effect of experimental freezing of bile ducts. Surgery 1967; 61: 748–54
   PubMedGoogle Scholar
• Franco D. Hepatocellular carcinoma in cirrhosis: the European experience. Eur Clin Digest Dis 1992; 1: 84–5
   Google Scholar
• Arii S, Tobe T. Results of surgical treatment; follow up study by Liver Cancer Study Group of Japan. Primary liver cancer in Japan, T Tobe. Springer-Verlag, Tokyo 1992; 243–55
   Google Scholar
• Iwatsuki S, Starzl T E. Experience with resection of primary hepatic malignancy. Surg Clin North Am 1989; 69: 315–22
   PubMed Web of Science ®Google Scholar
• Franco D, Smadja C. Results of resection of HCC in cirrhotic patients. An analysis of the European experience. Hepatogastroenterol 1992; 39: 111–5
   Google Scholar
• Nagasue N, Yukaya H, Ogawa Y. Clinical experience with 118 hepatic resections for hepatocellular carcinoma. Surgery 1986; 99: 694–701
   PubMed Web of Science ®Google Scholar
• Iwatsuki S, Starzl T E. Personal experience with 411 hepatic resections. Ann Surg 1988; 208: 421–34
   PubMed Web of Science ®Google Scholar
• Tsuzuki T, Sugioka A, Ueda M. Hepatic resection for hepatocellular carcinoma. Surgery 1990; 107: 511–20
   PubMed Web of Science ®Google Scholar
• Iwatsuki S, Starzl T E, Sheahan D G. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 1991; 214: 221–8
   PubMed Web of Science ®Google Scholar
• Harada T, Kodama S, Matsuo K. Surgical management of large hepatocellular carcinomas: criteria for curative hepa-tectomy. Int Surg 1993; 78: 284–7
   PubMed Web of Science ®Google Scholar
• Capussotti L, Borgonovo G, Bouzari H. Results of major hepatectomy for large primary liver cancer in patients with cirrhosis. Br J Surg 1994; 81: 427–31
   PubMed Web of Science ®Google Scholar
• Bengmark S, Jeppsson B. Status of ischaemic therapy for hepatic tumours. Surg Clin North Am 1989; 69: 411–8
   PubMed Web of Science ®Google Scholar
• Nagao T, Inone S, Yoshimi F. Postoperative recurrence of hepatocellular carcinoma. Ann Surg 1990; 211: 28–33
   PubMed Web of Science ®Google Scholar
• Jwo S C, Chiu J H, Chau G Y. Risk factors linked to tumour recurrence of human hepatocellular carcinoma after hepatic resection. Hepatology 1992; 16: 1367–71
   PubMed Web of Science ®Google Scholar
• Ikeda K, Saitoh S, Tsubota A. Risk factors for tumour recurrence and prognosis after curative resection of hepatocellular carcinoma. Cancer 1993; 71: 19–25
   PubMed Web of Science ®Google Scholar
• Ringe B, Wittekind C, Bechstein W O. The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumour stage and recurrence. Ann Surg 1989; 209: 88–98
   PubMed Web of Science ®Google Scholar
• O'Grady J G, Poison R J, Rolles K., Calne R Y, Williams R. Liver transplantation for malignant disease. Results in 93 consecutive patients. Ann Surg 1988; 207: 373–9
   PubMed Web of Science ®Google Scholar
• Pichlmayr R, Weimann A, Steinhoff G, Ringe B. Liver transplantation for hepatocellular carcinoma: clinical results and future aspects. Cancer Chemother Pharmacol 1992; 31(Suppl. I)S157–61
   Google Scholar
• Yokoyama I, Todo S, Iwatsuki S, Starzl T E. Liver transplantation in the treatment of primary liver cancer. Hepatogastroenterol 1990; 37: 188–93
   PubMed Web of Science ®Google Scholar
• Olthoff K M, Millis M, Rosove M H. Is liver transplantation justified for the treatment of hepatic malignancies?. Arch Surg 1990; 125: 1261–8
   PubMedGoogle Scholar
• Chung S W, Toth J L, Rezieg M. Liver transplantation for hepatocellular carcinoma. Ann J Surg 1994; 167: 317–21
   PubMed Web of Science ®Google Scholar
• Romani F, Belli L S, Rondinara G F. The role of transplantation in small hepatocellular carcinoma complicating cirrhosis of the liver. J Am Coll Surg 1994; 178: 379–84
   PubMed Web of Science ®Google Scholar
• Bismuth H, Chiche L, Adam R. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 1993; 218: 145–51
   PubMed Web of Science ®Google Scholar
• Nevenstone S, Friedman M A. Medical treatment of hepatocellular carcinoma. Gastroenterol Clin North Am 1987; 16: 603–12
   PubMed Web of Science ®Google Scholar
• Lai C L, Wu P C, Chan G C. Doxorubicin versus no antitumour therapy in inoperable hepatocellular carcinoma. Cancer 1988; 62: 479–83
   PubMed Web of Science ®Google Scholar
• Sciarrino E, Simonetti R G, Lemoli S. Adriamycin treatment for hepatocellular carcinoma. Cancer 1985; 56: 251–75
   Web of Science ®Google Scholar
• Falkson G, Cnaan A, Schutt A J. Prognostic factors for survival in hepatocellular carcinoma. Cancer Res 1988; 48: 7314–8
   PubMed Web of Science ®Google Scholar
• Ihde D C, Matthews M J, Makuch R W. Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy: identification of two groups of patients with prospects for prolonged survival. Ann J Med 1985; 78: 399–406
   PubMed Web of Science ®Google Scholar
• Friedman M A, Demanes D J, Hoffman P G, Jr. Hepatomas: Hormone receptors and therapy. Am J Med 1982; 73: 362–6
   PubMed Web of Science ®Google Scholar
• Gupta S, Korula J. Failure of ketoconazole as anti-androgen therapy in nonresectable primary hepatocellular carcinoma. J Clin Gastroenterol 1988; 10: 651–4
   PubMed Web of Science ®Google Scholar
• Patt Y Z, Chuang V P, Wallace S. Hepatic arterial chemotherapy and occlusion for palliation of primary hepatocellular and unknown primary neoplasms in the liver. Cancer 1983; 51: 1359–63
   PubMed Web of Science ®Google Scholar
• Fujimoto S, Miyazaki M, Endoh F. Biodegradable mitomycin C microspheres given intraarterially for inoperable hepatic cancer. Cancer 1985; 56: 2404–10
   PubMed Web of Science ®Google Scholar
• Shepmero F A, Evans W K, Blackstein M F. Hepatic arterial infusion of mitoxantrone in the treatment of primary hepatocellular carcinoma. J Clin Oncol 1987; 5: 635–40
   PubMed Web of Science ®Google Scholar
• Liu Y K, Yang K Z, Wu Y D. Treatment of advanced primary hepatocellular carcinoma by 131I anti-AFP. Lancet 1983; 1: 531–2
   PubMed Web of Science ®Google Scholar
• Bretagne J F, Raoul J L, Bourguet P. Hepatic artery injection of I 131 labelled lipiodol. Radiology 1988; 168: 547–50
   PubMedGoogle Scholar
• Forbes A, Johnson P J, Williams R. Recombinant human gamma interferon in primary hepatocellular carcinoma. J R Soc Med 1985; 78: 826–9
   PubMed Web of Science ®Google Scholar
• Sachs E, Di Bisceglie A M, Dusheiko G M. Treatment of hepatocellular carcinoma with recombinant leucocyte interferon: a pilot study. Br J Cancer 1985; 52: 105–9
   PubMed Web of Science ®Google Scholar
• Creagan E T, Long H J, Frytak S. Recombinant leucocyte A interferon with doxorubicin. A phase I study in advanced solid neoplasm and implication for hepatocellular carcinoma. Cancer 1988; 61: 19–22
   PubMed Web of Science ®Google Scholar
• Rosenberg S A, Lotze M T, Muul L M. Observations on the systemic administration of autologous lymphokine-acti-vated killer cell and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med 1985; 313: 1485–92
   PubMed Web of Science ®Google Scholar
• Hsieh K H, Shu S, Le C S. Lysis of primary hepatic tumours of lymphokine-activated killer cells. Gut 1987; 28: 117–24
   PubMed Web of Science ®Google Scholar
• Sitzmann J, Order S, Klein J. Conversion by new treatment modalities of nonresectable to resectable hepatocellular cancer. J Clin Oncol 1987; 5: 1566–73
   PubMed Web of Science ®Google Scholar
• Sitzmann J, Abrams R. Improved survival for hepatocellular cancer with combination surgery and multimodality treatment. Ann Surg 1993; 217: 149–54
   PubMed Web of Science ®Google Scholar
• Yu Y Q, Xu D B, Zhou X D. Experience with liver resection after hepatic arterial chemoembolisation for hepatocellular carcinoma. Cancer 1993; 71: 62–5
   PubMed Web of Science ®Google Scholar
• Rustgi V K. Epidemiology of hepatocellular carcinoma. Ann Intern Med 1988; 108: 390–1
   PubMedGoogle Scholar
• Pichlmayr R, Ringe B, Bechstein W O. Approach to primary liver cancer. Recent Results Cancer Res 1988; 110: 65–73
   PubMedGoogle Scholar
• Macintosh E L, Minuk G Y. Hepatic resection in patients with cirrhosis and hepatocellular carcinoma. Surg Gynecol Obstet 1992; 174: 245–54
   PubMedGoogle Scholar
• Franco D, Capussotti L, Smadja C. Resection of hepatocellular carcinomas. Results in 72 European patients with cirrhosis. Gastroenterology 1990; 98: 773–8
   PubMed Web of Science ®Google Scholar
• Sakon M, Monden M, Umeshita K. The prognostic significance of macroscopic growth pattern of hepatocellular carcinoma. Int Surg 1994; 79: 38–42
   PubMed Web of Science ®Google Scholar
• Yamamoto J, Kosuge T, Takayama T. Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy. Surgery 1994; 115: 303–9
   PubMed Web of Science ®Google Scholar
• Habib N, Zografos G, Koh M. Changing trends in hepatic resection for malignant liver tumours. Int Surg 1993; 78: 292–4
   PubMed Web of Science ®Google Scholar
• Ezaki T. Hepatocellular carcinoma. Br Med J 1992; 304: 196–7
   PubMedGoogle Scholar
• Taniguchi K, Nakata K, Kato Y. Treatment of hepatocellular carcinoma with transcatheter arterial embolisation. Analysis of prognostic factors. Cancer 1994; 73: 1341–5
   PubMed Web of Science ®Google Scholar
• Gage A A. Cryosurgery in the treatment of cancer. Surg Gynecol Obstet 1992; 174: 73–92
   PubMedGoogle Scholar
• Sato Y, Nakata K, Kato Y. Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein. N Engl J Med 1993; 328: 1802–6
   PubMed Web of Science ®Google Scholar